Walters Group insider trades
Open-market stock purchases and sales by Walters Group, 10% Owner at Zentalis Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 31, 2025.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +208%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 31, 2025 | ZNTL Zentalis Pharmaceuticals, Inc | Bought | $7.8M |
Companies traded
- ZNTL Zentalis Pharmaceuticals, Inc: 1 buy, last Dec 31, 2025